Research

(EN) EKBG – Lp(a)

A revolutionary drug for lowering Lp(a) levels in patients at cardiovascular risk or who have experienced a cardiovascular event.

Cardurion

We are launching this trial for you in 2026. A trial designed for patients with heart failure and reduced ejection fraction.

ZENITH

We’re launching it for you in 2026. A new injectable medication administered twice a year, intended for patients with hypertension to normalize blood pressure levels.

ELEVATE-HF

We’re launching it for you in 2026. A new medication for patients with heart failure who have preserved or mildly reduced ejection fraction.

(EN) Cardurion – Cycle 1

AZURE-HeFH

A breakthrough medication in tablet form for lowering LDL cholesterol in patients with familial hypercholesterolemia.

EASi-PROKTK

Vicadrostat for the prevention of cardiovascular events in patients with hypertension, diabetes, and other comorbidities.

AZURE-outcome

A breakthrough medication in tablet form for lowering LDL cholesterol as primary and secondary prevention of cardiovascular events.

STOP AHF: Telemonitoring of Heart Failure patients

Helping patients with heart failure: Prevention of acute heart failure hospitalizations

Librexia-ACS

Milvexian treatment in patients after overcoming a heart attack

SOS-AMI

Selatogrel as first aid in patients at risk of recurrent heart attack

Victorion-1 Prevent

Application of inclisiran as primary prevention in at-risk patients